• Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Average Recommendation of "Moderate Buy" by Analysts

    Source: Buzz FX / 15 Nov 2024 04:36:18   America/New_York


    Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat November 15, 2024 Share Link copied to clipboard. Shares of Viridian Therapeutics, Inc.
    Read more...
Share on,